Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials
Background: Rosuvastatin is an effective treatment for patients with hypercholesterolaemia.
However, the incremental benefit and risk of increasing through the licensed dose range …
However, the incremental benefit and risk of increasing through the licensed dose range …
[HTML][HTML] Lipid-lowering efficacy and safety of a new generic rosuvastatin in Koreans: an 8-week randomized comparative study with a proprietary rosuvastatin
Objective The aim of this study was to investigate whether a new generic rosuvastatin is non-
inferior to a proprietary one in terms of lipid-lowering efficacy. We also evaluated its non-lipid …
inferior to a proprietary one in terms of lipid-lowering efficacy. We also evaluated its non-lipid …
Achievement of English National Service Framework lipid‐lowering goals: pooled data from recent comparative treatment trials of statins at starting doses
FDR Hobbs, H Southworth - International journal of clinical …, 2005 - Wiley Online Library
Despite the importance of reducing cardiovascular disease (CVD) risk, detailed in
guidelines in many countries, repeated surveys show poor physician performance in …
guidelines in many countries, repeated surveys show poor physician performance in …
Randomized Head-to-Head Comparison of Pitavastatin, Atorvastatin, and Rosuvastatin for Safety and Efficacy (Quantity and Quality of LDL)–The PATROL Trial–
K Saku, B Zhang, K Noda… - Circulation …, 2011 - jstage.jst.go.jp
Background: Atorvastatin, rosuvastatin and pitavastatin are available for intensive,
aggressive low-density lipoprotein cholesterol (LDL-C)-lowering therapy in clinical practice …
aggressive low-density lipoprotein cholesterol (LDL-C)-lowering therapy in clinical practice …
Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial
W Insull Jr, JK Ghali, DR Hassman, JW Ycas… - Mayo Clinic …, 2007 - Elsevier
OBJECTIVE To evaluate attainment of the National Cholesterol Education Program (NCEP)
Adult Treatment Panel (ATP) III low-density lipoprotein cholesterol (LDL-C) goal of less than …
Adult Treatment Panel (ATP) III low-density lipoprotein cholesterol (LDL-C) goal of less than …
Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials
F Colivicchi, C Sternhufvud… - … and Outcomes Research, 2015 - Taylor & Francis
Objective No clinical trials have been conducted to directly compare the effect of the two
high-intensity statins, rosuvastatin and atorvastatin, on cardiovascular outcomes. However …
high-intensity statins, rosuvastatin and atorvastatin, on cardiovascular outcomes. However …
[HTML][HTML] Rosuvastatin: role in cardiovascular high-risk patient
JE Feliciano-Alfonso - Revista de la Facultad de Medicina, 2013 - scielo.org.co
Statins are the lipid-lowering drug family of first choice in situations of hypercholesterolemia
or mixed dyslipidemia with predominant increase in cholesterol. The evidence shows …
or mixed dyslipidemia with predominant increase in cholesterol. The evidence shows …
[HTML][HTML] Fasttrack: Editor's choice: Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the …
PM Ridker, S Mora, L Rose - European Heart Journal, 2016 - ncbi.nlm.nih.gov
Aims Current statin guidelines in Europe and Canada advocate achieving a fixed LDL target
or the attainment of a≥ 50% reduction in low-density lipoprotein cholesterol (LDLC), while …
or the attainment of a≥ 50% reduction in low-density lipoprotein cholesterol (LDLC), while …
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
C Berne, A Siewert-Delle… - Cardiovascular …, 2005 - Springer
Abstract Objective The Use of Rosuvastatin versus Atorvastatin iN type 2 diabetes mellitUS
(URANUS) study compared rosuvastatin with atorvastatin for the reduction of low-density …
(URANUS) study compared rosuvastatin with atorvastatin for the reduction of low-density …
Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP …
NJ Carter - American journal of cardiovascular drugs, 2010 - Springer
Rosuvastatin (Crestor®) is an HMG-CoA reductase inhibitor (statin) that has both lipid-
lowering and anti-inflammatory effects. The drug has various indications in the US, including …
lowering and anti-inflammatory effects. The drug has various indications in the US, including …